Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCherry Bo-Htayen_US
dc.contributor.authorThazin Shween_US
dc.contributor.authorSiriporn C. Chattipakornen_US
dc.contributor.authorNipon Chattipakornen_US
dc.description.abstract© 2019 Elsevier Inc. All rights reserved. Aging is an inevitable, complex biological process caused by a variety of factors including both genetic and environmental influences. It is one of the prime risk factors for the advancement of many pathological conditions such as cardiovascular diseases and neurodegenerative disorders. Numerous animal models have been used to add to our understanding of the aging process, to inform therapeutic interventions, and to limit the aging effects on various organs. Of these models the d-galactose-induced aging model is the most commonly used as a mimetic aging model. Despite the frequent use of this model, actually, how d-galactose accelerates cardiac and brain aging remains unclear. Currently, hyperbaric oxygen therapy (HBOT) is used to treat neurodegeneration and brain injury. This chapter comprehensively summarizes recent results from d-galactose treatment in both in vitro and in vivo cardiac and brain aging experiments and the different aspects of therapeutic interventions, in particular HBOT.en_US
dc.subjectAgricultural and Biological Sciencesen_US
dc.titleThe role of d-galactose in the aging heart and brainen_US
article.title.sourcetitleMolecular Nutrition Carbohydratesen_US Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.